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Abstract
Objective: To determine the impact of poor glycaemic
control on the prevalence of erectile dysfunction among
men with type 2 Diabetics aged 27 to 85 years.
Design: The databases Embase classic+Embase, Global
health, Ovid Medline and PsychINFO, were searched for
relevant studies in June 2014 using the keywords: (Diabetes
Mellitus OR diabetes mellitus type2 OR DM2 OR T2DM
OR insulin resistance) AND (erectile dysfunction OR
sexual dysfunction OR impotence) AND glycaemic control.
Setting: All study settings were considered (primary care,
secondary care and tertiary care setting).
Participants: Type 2 Diabetic Patients with erectile
dysfunction.
Main outcome measures: Included studies must include
one of the following outcomes: (1) HBA1c for assess the
level of glycaemic control; (2) Erectile dysfunction (any
stage: IIEF-5 = 21 or less).
Results: Five cross-sectional studies involving 3299 patients
were included. The findings pointed to a positive association
between erectile dysfunction and glycaemic control. Three
studies showed a significant positive association, while one
study showed only aweak correlation and one study showed
borderline significance. Patients’ age, diabetes mellitus dur-
ation, peripheral neuropathy and body mass index had posi-
tive association with erectile dysfunction. However, smoking
and hypertension were not associated with erectile dysfunc-
tion in most included studies. Physical activity had a protect-
ive effect against erectile dysfunction.
Conclusion: We may conclude that the risk of erectile
dysfunction is higher in type 2 diabetic men with poor gly-
caemic control than those with good control.
Keywords
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Introduction
Erectile dysfunction (ED) is deﬁned as the inability to
achieve and/or maintain penile erection suﬃcient for
satisfactory sexual intercourse.1 ED is a common
problem in men with a history of diabetes mellitus
(DM).2 The prevalence of ED among patients with
history of type 1 and/or type 2 DM in the literature
varies from 35% to 90%.3–12 Literature including
patients with history of type 2 DM only shows the
prevalence of ED severity, by international index
of erectile function (IIEF), as 73.10%,10 86.10%11
and 90%.12
Diabetic men have almost a threefold higher prob-
ability to develop ED compared with non-diabetics;13
they are also prone for the onset of ED to occur 10 to
15 years earlier than in non-diabetic men.13 ED in
diabetic men has also been shown to be more severe
and associated with a poorer quality of life.14 It is less
responsive to medical treatment compared with ED
in non-diabetic men.15 However, it is still unclear
whether ED in diabetic men is a consequence only
of hyperglycaemia and microvascular complications
or a collection of risk factors, as the patients often
present with other ED risk factors, such as cardiovas-
cular diseases, hypertension, smoking and obesity at
the same time.16
The importance of poor glycaemic control as an
indicator of reduced erectile function in diabetic men
is still unclear. Several studies have demonstrated a
signiﬁcant correlation between the two;11,17–21 how-
ever, some studies have been mixed as to whether
there is a statistically signiﬁcant correlation between
ED and poor glycaemic control, showing only a bor-
derline correlation8,22,23 or no correlation at all.24–26
The inconsistency in the literature means that further
studies are needed to clarify a causal link between pro-
longed hyperglycaemia and ED. This disparity between
studies may be the result of the sample sizes used and
multivariate strategies used to analyse the data.
In our review, we aim to clearly determine the
impact of poor glycaemic control on the prevalence
of ED in men with type 2 DM, as well as the impact
of other possible risk factors, such as duration of
DM, patients’ age, hypertension and cigarette smok-
ing on the prevalence of ED.
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Methods
The databases Embase classicþEmbase from 1947,
Global health from 1973, Ovid Medline from 1946
and PsychINFO from 1967 were searched for rele-
vant studies in June 2014 using the keywords:
(Diabetes Mellitus OR diabetes mellitus type 2 OR
DM2 OR T2DM OR insulin resistance) AND (erect-
ile dysfunction OR sexual dysfunction OR impo-
tence) AND glycaemic control.
In consultation with the research team, we con-
sidered any observational study at any clinical settings
that explored the impact of glycaemic control level on
the prevalence of ED in men with type 2 DM. The
inclusion criteria for the participants were any patient
with type 2 DM, aged between 27 and 85 years. The
primary outcome must include: glycaemic control
which was measured by glycosylated haemoglobin
(HBA1c) and diagnosis of ED was done by using the
international index of erectile function (IIEF-5). We
deﬁned poor glycaemic control as HBA1c more than
7% (53 mmol/mol) and ED, if IIEF-5 is equal to or
less than 21.27 Our secondary outcomes were the
impact of other possible risk factors on the prevalence
of ED for men with T2DM, e.g. duration of DM,
patients’ age, hypertension and smoking. Searching
was restricted to articles in the English language.
Two reviewers (TB and SH) performed the search
and reviewed the results. The duplicate studies were
removed using EndNote. During the initial review for
titles and abstracts, studies that did not meet our
criteria were excluded. If the reviewers were uncertain
about certain studies during the initial review, then
the full text article was assessed. Independently, two
reviewers (TB and SH) assessed all relevant studies.
Disagreement had been resolved by discussion and
external opinion had been requested if needed.
Two reviewers (TB and SS) independently assessed
the included studies for quality. Full critical appraisal
was done for each study, by using Newcastle Ottawa
quality assessment tool for cohort studies; checklists
were adapted to be applied for cross-sectional stu-
dies.28 Items reviewed included representativeness of
the sample; sample size; response rate; validity of
measurement tool, if validated and if non-validated;
study controls for the most important factor and add-
itional factors; assessment of the outcome; and stat-
istical test used.
After the data extraction form was developed, two
reviewers (TB and SS) independently extracted the
data from included studies on the prevalence of ED
among type 2 DM and the correlation between gly-
caemic control and other risk factors with ED.
p values were used for the magnitude of the eﬀect.
Results
Our electronic search identiﬁed 379 studies (Figure 1,
PRISMA ﬂow chart), of which 68 duplicated studies
were excluded. An additional 289 studies were
excluded after title and abstract review as they did
not meet our inclusion criteria, leaving 22 studies;
of these 22 studies, 17 studies were further excluded
on reviewing their full text. The main reasons for
exclusion were that type 1 diabetic patients were
included and some studies did not measure the asso-
ciation between the ED prevalence and glycaemic
control.
We found one additional study11 through bibliog-
raphy hand searches; also one study29 was excluded
because the author did not respond to our query
about the assessment of DM control. Five studies
were ﬁnally included in this systematic
review;8,11,17,20,23 they were all of cross-sectional
design. Table 1 summarises the characteristics and
the main ﬁndings of the ﬁve included studies.
Studies included were published between 2000 and
2010. Total sample size was 3299 patients; they were
conducted in the USA (78 participants), Italy (555
participants), Korea (1312 participants), Taiwan
(792 participants) and Saudi Arabia (562 partici-
pants). Mean ageSD were 62 12.3 years,17
57.9 6.9 years,20 53.8 6.65 years,8 65.6 13.2
years23 and 53.7 10.8 years.11 Mean HBA1c SD
were 8.1 1.9%,17 8.4 1.3%,20 7.9 1.83%,8
8.2 2.0%23 and there were no data from El-Sakka
and Tayeb.11 Mean DM duration were 4.9 1.5
years,20 9.0 7.5 years,23 10.8 7.5 years,11 median
DM duration was six years8 and there were no data
from Romeo et al.17 Regarding all degrees of ED, the
prevalence were 60%,20 65.4%,8 83.6%,23 86.1%11
and data were not shown in one study.17
The highest score of quality assessment is 9 points
and the lowest score is 7 points, which demonstrate a
good quality of included studies.
The ﬁndings generally pointed to a positive
association between ED and glycaemic control.
Three studies showed a signiﬁcant positive associ-
ation,11,17,20 while one study showed only a weak
correlation8 and one study showed a borderline sig-
niﬁcant association.23
In El-Sakka and Tayeb,11 there was a higher like-
lihood of 12.2 times of patients with poor glycaemic
control to suﬀer ED as compared with their counter-
parts with good glycaemic control. In the study by
Romeo et al.,17 the researchers showed that HBA1c
was an independent predictor of EF score (p< 0.001).
In Giugliano et al.,20 there was a higher average level
of HBA1c in diabetic men with ED than in those who
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do not have ED (8.7 1.0% vs. 7.9 0.9%, p¼ 0.01).
Meanwhile, in the largest study,8 the data from 1312
Korean men with type 2 DM, after using multivariate
logistic regression to recognise independent risk fac-
tors for all types of ED, only a weak independent
connection with the occurrence of diabetic-related
ED was shown by HBA1c (p 0.092). In Lu et al.,23
men suﬀering from ED had signiﬁcantly higher aver-
age HBA1c level compared with those not suﬀering
from ED in the youthful age group (8.8 2.2 vs.
7.9 2.0%, p< 0.0009); however, no signiﬁcant dif-
ference in mean HBA1c level between men with ED
and those not suﬀering among the older age group
(8.0 1.8% vs. 8.1 2.0%, p¼ 0.63). There was also
a signiﬁcant higher mean HBA1c level in those with
severe ED than in those with no severe ED among the
youth (9.6 2.3 vs. 8.3 2.1%, p¼ 0.0002), while
mean HBA1c level did not show signiﬁcant diﬀerence
between those with severe ED and those who did not
have it among the older generation (8.0 1.9 vs.
8.0 1.7%, p¼ 0.99).
Patients’ age, DM duration, peripheral neur-
opathy and body mass index had positive association
with ED. However, smoking and hypertension were
not associated with ED in most included studies.
Physical activity had a protective eﬀect against ED.
Figure 1. Flow chart showing search findings.
Records idenﬁed though searching data bases (Embase, Medline, Global health and 
PsychINFO) using the key words:
Diabetes mellitus OR diabetes mellitus type 2 OR DM2 OR T2DM OR insulin resistance AND
erecle dysfuncon OR sexual dysfuncon OR impotence AND glycemic control.
379
68 duplicate studies 
were excluded
311 studies aer 
duplicates excluded
289 studies on 
tles and abstracts 
were excluded
22 studies aer tles 
and abstracts were 
excluded
17 studies were 
excluded aer reading 
the full texts
5 studies were 
included aer 
reading the full texts
5 studies were included
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reviewing the references
Binmoammar et al. 3
 at Imperial College London Library on March 10, 2016shr.sagepub.comDownloaded from 
T
a
b
le
1
.
D
at
a
e
x
tr
ac
te
d
fr
o
m
ar
ti
cl
e
s.
St
u
d
y
O
b
je
ct
iv
e
o
f
st
u
d
y
Sa
m
p
le
ch
ar
ac
te
ri
st
ic
s
O
u
tc
o
m
e
s
C
o
n
fo
u
n
d
e
rs
in
cl
u
d
e
d
Se
x
u
al
fu
n
ct
io
n
in
m
e
n
w
it
h
d
ia
b
e
te
s
ty
p
e
2
:
as
so
ci
at
io
n
w
it
h
gl
yc
ae
m
ic
co
n
tr
o
l
R
o
m
e
o
e
t
al
.1
7
C
ro
ss
-s
e
ct
io
n
al
st
u
d
y,
O
h
io
To
e
va
lu
at
e
th
e
as
so
ci
at
io
n
o
f
gl
yc
ae
m
ic
co
n
tr
o
l
w
it
h
E
D
in
m
e
n
w
it
h
ty
p
e
2
D
M
–
To
ta
l
st
u
d
y
p
o
p
u
la
ti
o
n
:
7
8
–
M
e
an
ag
e
:
6
2
.0

1
2
.3
ye
ar
s
(3
8
–
8
2
)
–
M
e
an
H
B
A
1
c:
8
.1
%

1
.9
%
(5
.2
–
1
5
.6
)
–
M
e
an
E
F
sc
o
re
:
1
6
.6

5
.9
(5
–
2
3
)
–
A
ft
e
r
E
F
sc
o
re
s
w
e
re
st
ra
ti
fie
d
b
y
th
e
le
ve
l
o
f
gl
yc
ae
m
ic
co
n
tr
o
l:
–
M
e
an
E
F
sc
o
re
d
e
cr
e
as
e
d
as
H
B
A
1
c
in
cr
e
as
e
d
(a
n
al
ys
is
o
f
va
ri
an
ce
p
¼
0
.0
0
2
)
–
A
ft
e
r
b
iv
ar
ia
te
an
al
ys
is
,
to
e
x
am
in
e
th
e
co
rr
el
at
io
n
o
f
E
D
w
it
h
su
b
je
ct
ch
ar
ac
te
ri
st
ic
s:
T
h
e
re
w
as
a
si
gn
ifi
ca
n
t
co
rr
e
la
ti
o
n
o
f
H
B
A
1
c
w
it
h
n
e
u
ro
p
at
hy
b
u
t
n
o
t
w
it
h
p
ar
ti
ci
p
an
t
ag
e
,
d
u
ra
ti
o
n
o
f
D
M
o
r
so
m
e
m
e
d
ic
at
io
n
u
se
(d
at
a
n
o
t
sh
o
w
n
)
–
M
u
lt
iv
ar
ia
te
an
al
ys
is
sh
o
w
ed
th
at
H
B
A
1
c
w
as
an
in
d
e
-
p
e
n
d
e
n
t
p
re
d
ic
to
r
o
f
E
F
sc
o
re
(p
<
0
.0
0
1
)
e
ve
n
af
te
r
ad
ju
st
in
g
fo
r
p
e
ri
p
h
e
ra
l
n
e
u
ro
p
at
hy
,
w
h
ic
h
w
as
al
so
an
in
d
e
p
e
n
d
e
n
t
p
re
d
ic
to
r
(p
¼
0
.0
2
3
)
–
W
h
e
n
su
b
je
ct
ag
e
an
d
D
M
d
u
ra
ti
o
n
w
e
re
in
cl
u
d
e
d
in
m
u
lt
iv
ar
ia
te
m
o
d
e
ls
,
o
n
ly
H
B
A
1
c
an
d
n
e
u
ro
p
at
hy
w
e
re
si
gn
ifi
ca
n
t
in
d
e
p
e
n
d
e
n
t
p
re
d
ic
to
rs
o
f
E
F
sc
o
re
–
H
B
A
1
c
–
A
ge
–
D
M
d
u
ra
ti
o
n
–
P
e
ri
p
h
e
ra
l
n
e
u
ro
p
at
hy
–
So
m
e
m
e
d
ic
at
io
n
s
D
e
te
rm
in
an
ts
o
f
e
re
ct
ile
d
ys
fu
n
ct
io
n
in
ty
p
e
2
d
ia
b
e
te
s
F
G
iu
gl
ia
n
o
e
t
al
.2
0
C
ro
ss
-s
e
ct
io
n
al
st
u
d
y,
N
ap
le
s
(I
ta
ly
)
To
e
va
lu
at
e
th
e
p
re
va
le
n
ce
an
d
co
rr
el
-
at
e
s
o
f
E
D
in
a
p
o
p
u
la
ti
o
n
o
f
d
ia
b
e
ti
c
m
e
n
–
To
ta
l
st
u
d
y
p
o
p
u
la
ti
o
n
:
5
5
5
–
A
ll
E
D
:
3
3
3
(6
0
%
)
–
M
ild
:
9
%
–
M
ild
to
m
o
d
e
ra
te
:
1
1
.2
%
–
M
o
d
e
ra
te
:
1
6
.9
%
–
Se
ve
re
:
2
2
.9
%
–
M
e
an
ag
e
:
5
7
.9

6
.9
ye
ar
s
(3
5
–
7
0
)
–
M
e
an
H
B
A
1
c
8
.4
%

1
.3
%
–
M
e
an
D
M
d
u
ra
ti
o
n
:
4
.9

1
.5
ye
ar
s
C
o
n
tr
ib
u
ti
o
n
o
f
d
iff
e
re
n
t
ri
sk
fa
ct
o
rs
to
ri
sk
o
f
E
D
in
th
e
d
ia
b
e
ti
c
p
o
p
u
la
ti
o
n
(b
as
e
d
o
n
m
u
lt
iv
ar
ia
te
lo
gi
st
ic
re
gr
es
si
o
n
):
1
-A
ge
(O
R
1
.1
0
)
9
5
%
C
I
1
.0
5
–
1
.1
5
(p
0
.0
0
1
)
2
-D
M
d
u
ra
ti
o
n
(O
R
1
.0
5
)
9
5
%
C
I
1
.0
1
–
1
.1
0
(p
0
.0
1
)
3
-H
B
A
1
c
(O
R
1
.1
8
)
9
5
%
C
I
1
.0
2
–
1
.3
7
(p
0
.0
3
)
4
-M
S
(O
R
2
.0
8
)
9
5
%
C
I
1
.1
7
–
3
.2
6
(p
0
.0
1
)
5
-B
M
I
(O
R
1
.0
3
)
9
5
%
C
I
1
.0
0
–
1
.0
7
(p
0
.0
4
)
6
-W
H
R
^
(O
R
1
.0
4
)
9
5
%
C
I
1
.0
1
–
1
.0
8
(p
0
.0
3
)
7
-H
T
N
(O
R
1
.3
4
)
9
5
%
C
I
1
.0
8
-2
.0
3
(p
0
.0
2
)
8
-D
L
D
(O
R
1
.2
3
)
9
5
%
C
I
1
.0
4
–
1
.4
9
(p
0
.0
1
)
9
-C
ig
ar
e
tt
e
sm
o
k
in
g:
a-
p
as
t
(O
R
1
.1
5
)
9
5
%
C
I
0
.8
6
–
1
.9
8
(p
0
.5
6
)
n
o
t
si
gn
ifi
ca
n
t
b
-c
u
rr
en
t
(O
R
1
.3
6
)
9
5
%
C
I
0
.8
1
–
2
.0
9
(p
0
.3
5
)
n
o
t
si
gn
ifi
ca
n
t
1
0
-P
hy
si
ca
l
ac
ti
vi
ty
(O
R
0
.9
0
)
9
5
%
C
I
0
.7
7
–
0
.9
8
(p
0
.0
4
)
p
ro
te
ct
iv
e
o
f
E
D
1
1
-D
e
p
re
ss
io
n
(O
R
1
.0
9
)
9
5
%
C
I
1
.0
2
–
1
.1
9
(p
0
.0
3
)
T
h
e
m
e
an
H
B
A
1
c
le
ve
l
w
as
si
gn
ifi
ca
n
tl
y
h
ig
h
e
r
in
d
ia
b
e
ti
c
p
at
ie
n
ts
w
it
h
E
D
th
an
th
o
se
w
it
h
o
u
t
E
D
(8
.7

1
.0
%
vs
7
.9

0
.9
%
,
p
¼
0
.0
1
).
–
H
B
A
1
c
–
A
ge
–
D
M
d
u
ra
ti
o
n
–
M
e
ta
b
o
lic
sy
n
d
ro
m
e
–
B
M
I
–
W
H
R
–
H
T
N
–
D
L
D
–
C
ig
ar
e
tt
e
sm
o
k
in
g
–
P
hy
si
ca
l
ac
ti
vi
ty
–
D
e
p
re
ss
io
n
(c
o
n
ti
n
u
e
d
)
4 Journal of the Royal Society of Medicine Open 0(0)
 at Imperial College London Library on March 10, 2016shr.sagepub.comDownloaded from 
T
a
b
le
1
.
C
o
n
ti
n
u
e
d
.
St
u
d
y
O
b
je
ct
iv
e
o
f
st
u
d
y
Sa
m
p
le
ch
ar
ac
te
ri
st
ic
s
O
u
tc
o
m
e
s
C
o
n
fo
u
n
d
e
rs
in
cl
u
d
e
d
P
re
va
le
n
ce
o
f
e
re
ct
ile
d
ys
fu
n
ct
io
n
in
K
o
re
an
m
e
n
w
it
h
ty
p
e
2
D
M
C
h
o
e
t
al
.8
C
ro
ss
-s
e
ct
io
n
al
st
u
d
y,
M
ay
2
0
0
2
to
M
ar
ch
2
0
0
3
,
K
o
re
a
To
in
ve
st
ig
at
e
th
e
p
re
va
le
n
ce
an
d
ri
sk
fa
ct
o
rs
fo
r
d
ev
el
o
p
in
g
E
D
in
1
3
1
2
K
o
re
an
m
e
n
w
it
h
d
ia
b
e
te
s
–
To
ta
l
st
u
d
y
p
o
p
u
la
ti
o
n
:
1
3
1
2
–
A
ll
E
D
:
8
5
8
(6
5
.4
%
)
–
M
ild
:
2
0
.1
%
–
M
o
d
e
ra
te
:
1
9
.5
–
C
o
m
p
le
te
:
2
5
.8
%
–
M
e
an
ag
e
:
5
3
.8

6
.6
5
ye
ar
s
(4
0
–
6
4
)
–
M
e
an
H
B
A
1
c
7
.9
%

1
.8
3
%
–
M
e
d
ia
n
D
M
d
u
ra
ti
o
n
6
ye
ar
s
(r
an
ge
1
–
4
3
)
W
h
e
n
th
e
su
b
je
ct
s
w
e
re
st
ra
ti
fie
d
ac
co
rd
in
g
to
E
D
st
at
u
s
(N
o
rm
al
,
m
ild
,
m
o
d
e
ra
te
an
d
co
m
p
le
te
),
th
e
re
w
e
re
si
gn
ifi
-
ca
n
t
tr
e
n
d
s
re
la
ti
n
g
th
e
se
ve
ri
ty
o
f
E
D
to
:
1
-A
ge
(p
<
0
.0
0
1
)
2
-D
M
d
u
ra
ti
o
n
(p
<
0
.0
0
1
)
3
-F
as
ti
n
g
gl
u
co
se
(p
<
0
.0
5
)
4
-H
B
A
1
c
(p
<
0
.0
0
1
)
5
-D
u
ra
ti
o
n
o
f
al
co
h
o
l
co
n
su
m
p
ti
o
n
(p
<
0
.0
0
1
)
–
N
o
si
gn
ifi
ca
n
t
d
iff
e
re
n
ce
s
w
e
re
o
b
se
rv
ed
in
b
lo
o
d
p
re
s-
su
re
o
r
d
u
ra
ti
o
n
o
f
sm
o
k
in
g
O
th
e
r
ri
sk
fa
ct
o
rs
fo
r
E
D
w
e
re
e
x
am
in
e
d
:
1
-S
u
b
je
ct
s
w
h
o
e
x
e
rc
is
e
d
re
gu
la
rl
y
h
ad
ra
te
o
f
co
m
p
le
te
E
D
0
.6
2
ti
m
e
s
th
o
se
o
f
al
co
h
o
l
ab
st
ai
n
e
rs
o
r
se
d
e
n
ta
ry
su
b
je
ct
s
(9
5
%
C
I
0
.4
4
–
0
.8
9
,
p
<
0
.0
1
)
2
-S
u
b
je
ct
s
w
h
o
co
n
su
m
e
d
al
co
h
o
l
h
ad
ra
te
o
f
co
m
p
le
te
E
D
0
.4
9
ti
m
e
s
th
e
sa
m
e
co
m
p
ar
is
o
n
ab
o
ve
(9
5
%
C
I
0
.3
6
–
0
.6
6
,
p
<
0
.0
0
1
)
3
-S
u
b
je
ct
s
w
h
o
w
e
re
o
n
in
su
lin
tr
e
at
m
e
n
t
ar
e
6
.1
ti
m
e
s
m
o
re
lik
e
ly
to
h
av
e
co
m
p
le
te
E
D
th
an
n
o
n
-i
n
su
lin
u
se
rs
(9
5
%
C
I
3
.2
–
1
1
.4
,
p
<
0
.0
0
1
)
4
-S
u
b
je
ct
s
w
h
o
w
e
re
o
n
d
ie
t
th
e
ra
p
y
al
o
n
e
h
ad
ra
te
s
o
f
co
m
p
le
te
E
D
o
n
ly
0
.5
9
ti
m
e
s
o
f
th
o
se
re
ce
iv
in
g
th
e
o
th
e
r
tr
e
at
m
e
n
ts
(9
5
%
C
I
0
.3
6
–
0
.9
5
,
p
<
0
.0
0
1
)
5
-S
u
b
je
ct
s
w
it
h
e
it
h
e
r
n
e
u
ro
p
at
hy
o
r
m
ac
ro
va
sc
u
la
r
d
is
e
as
e
w
e
re
,
re
sp
e
ct
iv
el
y,
1
.8
ti
m
e
s
(9
5
%
C
I
1
.1
1
–
2
.9
,
p
<
0
.0
5
)
an
d
3
.5
ti
m
e
s
(9
5
%
C
I
1
.1
4
–
1
0
.6
,
p
<
0
.0
5
)
as
lik
e
ly
to
h
av
e
co
m
p
le
te
E
D
as
th
o
se
su
b
je
ct
s
w
it
h
o
u
t
su
ch
co
m
p
lic
at
io
n
s
6
-C
o
m
p
le
te
E
D
w
as
n
o
t
si
gn
ifi
ca
n
tl
y
re
la
te
d
to
e
it
h
e
r
H
T
N
o
r
sm
o
k
in
g
st
at
u
s
W
h
e
n
m
u
lt
ip
le
lo
gi
st
ic
re
gr
e
ss
io
n
an
al
ys
is
w
as
u
se
d
to
id
e
n
ti
fy
si
gn
ifi
ca
n
t
in
d
e
p
e
n
d
e
n
t
ri
sk
fa
ct
o
rs
fo
r
al
l
ty
p
e
s
o
f
E
D
:
1
-A
ge
(p
<
0
.0
0
1
)
2
-D
M
d
u
ra
ti
o
n
(p
<
0
.0
0
5
)
3
-N
e
u
ro
p
at
hy
(p
<
0
.0
5
)
4
-U
se
o
f
in
su
lin
(p
<
0
.0
0
1
)
5
-M
ac
ro
va
sc
u
la
r
co
m
p
lic
at
io
n
s
(p
0
.0
3
8
)
W
e
re
in
d
e
p
e
n
d
e
n
t
p
o
si
ti
ve
ri
sk
fa
ct
o
rs
fo
r
al
l
ty
p
e
s
o
f
E
D
.
B
u
t,
al
co
h
o
l
co
n
su
m
p
ti
o
n
(p
<
0
.0
5
)
an
d
e
x
e
rc
is
e
( p
<
0
.0
1
)
w
e
re
in
d
e
p
e
n
d
e
n
t
n
e
ga
ti
ve
ri
sk
fa
ct
o
rs
.
M
o
re
o
ve
r,
H
B
A
1
c
sh
o
w
e
d
o
n
ly
w
e
ak
(o
r
n
o
)
in
d
e
p
e
n
d
e
n
t
re
la
ti
o
n
sh
ip
w
it
h
th
e
d
ev
e
lo
p
m
en
t
o
f
d
ia
b
e
ti
c-
re
la
te
d
E
D
(p
0
.0
9
2
).
–
W
h
e
n
w
e
an
al
yz
e
d
th
e
d
at
a
fu
rt
h
e
r
u
si
n
g
co
m
p
le
te
E
D
as
th
e
d
e
p
e
n
d
e
n
t
va
ri
ab
le
,
th
o
se
va
ri
ab
le
s
al
so
sh
o
w
e
d
in
d
e
p
e
n
d
e
n
t
re
la
ti
o
n
sh
ip
w
it
h
al
lt
yp
e
s
o
f
E
D
w
it
h
e
x
ce
p
-
ti
o
n
o
f
n
e
u
ro
p
at
hy
.
–
H
B
A
1
c
–
A
ge
–
D
M
d
u
ra
ti
o
n
–
H
T
N
–
Sm
o
k
in
g
–
N
e
u
ro
p
at
hy
–
U
se
o
f
in
su
lin
–
M
ac
ro
va
sc
u
la
r
d
is
e
as
e
–
A
lc
o
h
o
l
co
n
su
m
p
ti
o
n
–
E
x
e
rc
is
e (
co
n
ti
n
u
e
d
)
Binmoammar et al. 5
 at Imperial College London Library on March 10, 2016shr.sagepub.comDownloaded from 
T
a
b
le
1
.
C
o
n
ti
n
u
e
d
.
St
u
d
y
O
b
je
ct
iv
e
o
f
st
u
d
y
Sa
m
p
le
ch
ar
ac
te
ri
st
ic
s
O
u
tc
o
m
e
s
C
o
n
fo
u
n
d
e
rs
in
cl
u
d
e
d
A
ss
o
ci
at
io
n
o
f
gl
yc
ae
m
ic
co
n
tr
o
l
w
it
h
ri
sk
o
f
e
re
ct
ile
d
ys
fu
n
ct
io
n
in
m
e
n
w
it
h
ty
p
e
2
d
ia
b
e
te
s
L
u
e
t
al
.2
0
C
ro
ss
-s
e
ct
io
n
al
st
u
d
y,
Ja
n
u
ar
y
2
0
0
4
–
M
ay
2
0
0
6
,
T
ai
w
an
To
e
va
lu
at
e
th
e
as
so
ci
at
io
n
o
f
gl
yc
ae
m
ic
co
n
tr
o
l
w
it
h
ri
sk
o
f
E
D
in
ty
p
e
2
d
ia
b
e
ti
cs
–
To
ta
l
st
u
d
y
p
o
p
u
la
ti
o
n
:
7
9
2
–
A
ll
E
D
:
6
6
2
(8
3
.6
%
)
–
M
ild
:
1
2
3
(1
5
.5
%
)
–
M
ild
to
m
o
d
e
ra
te
:
1
3
3
(1
6
.8
%
)
–
M
o
d
e
ra
te
:
6
4
(8
.1
%
)
–
Se
ve
re
:
3
4
2
(4
3
.2
%
)
–
M
e
an
ag
e
:
6
5
.6

1
3
.2
(2
7
–
8
5
)
–
M
e
an
d
u
ra
ti
o
n
o
f
D
M
:
9
.0

7
.5
(1
–
3
9
)
–
M
e
an
H
B
A
1
c:
8
.2
%

2
.0
%
(4
.3
–
1
7
.5
)
T
h
e
p
re
va
le
n
ce
o
f
E
D
w
as
p
o
si
ti
ve
ly
co
rr
el
at
e
d
w
it
h
su
b
-
je
ct
’s
ag
e
an
d
d
u
ra
ti
o
n
o
f
d
ia
b
e
te
s
(p
0
.0
0
0
)
H
ig
h
e
r
H
B
A
1
c
le
ve
l
w
as
as
so
ci
at
e
d
w
it
h
a
h
ig
h
e
r
ri
sk
o
f
E
D
w
it
h
b
o
rd
e
rl
in
e
si
gn
ifi
ca
n
ce
(p
¼
0
.0
5
9
)
–
T
h
e
O
R
s
o
f
E
D
fo
r
ri
sk
fa
ct
o
rs
(H
B
A
1
c,
H
T
N
,
D
L
D
an
d
ci
ga
re
tt
e
sm
o
k
in
g)
af
te
r
ad
ju
st
in
g
fo
r
ag
e
an
d
D
M
d
u
r-
at
io
n
:
o
n
ly
H
B
A
1
c
le
ve
l
w
as
si
gn
ifi
ca
n
tl
y
as
so
ci
at
e
d
w
it
h
E
D
ri
sk
(p
0
.0
3
4
)
–
T
h
e
p
re
va
le
n
ce
o
f
E
D
w
as
6
6
.7
%
in
yo
u
n
ge
r
gr
o
u
p
an
d
9
3
.1
%
in
th
e
o
ld
e
r
gr
o
u
p
(p
¼
0
.0
0
0
)
–
T
h
o
se
w
it
h
E
D
h
ad
a
si
gn
ifi
ca
n
tl
y
h
ig
h
e
r
m
e
an
H
B
A
1
c
le
ve
l
th
an
th
o
se
w
it
h
o
u
t
E
D
in
yo
u
n
ge
r
gr
o
u
p
(8
.8

2
.2
vs
7
.9

2
.0
%
,
p
<
0
.0
0
0
9
)
–
T
h
e
re
w
as
n
o
si
gn
ifi
ca
n
t
d
iff
e
re
n
ce
in
m
e
an
H
B
A
1
c
le
ve
l
b
e
tw
e
e
n
th
o
se
w
it
h
o
r
w
it
h
o
u
t
E
D
in
th
e
o
ld
e
r
gr
o
u
p
(8
.0

1
.8
vs
8
.1

2
.0
%
,
p
¼
0
.6
3
)
–
W
h
e
n
m
u
lt
iv
ar
ia
te
lo
gi
st
ic
re
gr
e
ss
io
n
w
as
u
se
d
fo
r
th
e
co
n
tr
ib
u
ti
o
n
o
f
ri
sk
fa
ct
o
rs
to
ri
sk
o
f
E
D
:
(1
)
in
yo
u
n
g
gr
o
u
p
(
<
6
0
):
a-
A
ge
O
R
1
.0
6
(9
5
%
C
I
1
.0
2
–
1
.1
0
)
p
0
.0
0
2
b
-D
M
d
u
ra
ti
o
n
O
R
1
.0
6
(9
5
%
C
I
1
.0
0
1
–
1
.1
2
)
p
0
.0
4
5
c-
H
B
A
1
c
O
R
1
.2
1
(9
5
%
C
I
1
.0
6
–
1
.3
9
)
p
0
.0
0
4
w
e
re
si
gn
ifi
ca
n
t
in
d
e
p
e
n
d
e
n
t
ri
sk
ac
to
rs
fo
r
E
D
(2
)
in
o
ld
gr
o
u
p
(>
6
0
):
a-
A
ge
O
R
1
.0
7
(9
5
%
C
I
1
.0
2
–
1
.1
3
)
p
0
.0
0
9
b
-D
M
d
u
ra
ti
o
n
O
R
1
.0
7
(9
5
%
C
I
1
.0
1
–
1
.1
4
)
p
0
.0
1
9
w
e
re
si
gn
ifi
ca
n
t
in
d
e
p
e
n
d
e
n
t
ri
sk
fa
ct
o
rs
fo
r
E
D
–
T
h
e
m
e
an
H
B
A
1
c
le
ve
l
w
as
si
gn
ifi
ca
n
tl
y
h
ig
h
e
r
in
th
o
se
w
it
h
se
ve
re
E
D
th
an
th
o
se
w
it
h
o
u
t
se
ve
re
E
D
am
o
n
g
th
e
yo
u
n
ge
r
gr
o
u
p
(9
.6

2
.3
vs
8
.3

2
.1
%
,
p
¼
0
.0
0
0
2
)
–
T
h
e
m
e
an
H
B
A
1
c
le
ve
l
d
id
n
o
t
sh
o
w
si
gn
ifi
ca
n
t
d
iff
e
r-
e
n
ce
b
e
tw
e
e
n
th
o
se
w
it
h
se
ve
re
E
D
an
d
th
o
se
w
it
h
o
u
t
am
o
n
g
th
e
o
ld
e
r
gr
o
u
p
(8
.0

1
.9
vs
8
.0

1
.7
%
,p
¼
0
.9
9
)
–
C
o
n
tr
ib
u
ti
o
n
o
f
H
B
A
1
c
an
d
o
th
e
r
ri
sk
fa
ct
o
rs
to
ri
sk
o
f
SE
V
E
R
E
E
D
b
as
e
d
o
n
m
u
lt
iv
ar
ia
te
lo
gi
st
ic
re
gr
es
si
o
n
:
(1
)
in
yo
u
n
g
gr
o
u
p
:
a-
D
M
d
u
ra
ti
o
n
O
R
1
.0
9
(9
5
%
C
I
1
.0
3
–
1
.1
6
)
p
0
.0
0
3
b
-H
B
A
1
c
O
R
1
.2
7
(9
5
%
C
I
1
.0
9
–
1
.4
9
)
p
0
.0
0
3
c-
H
T
N
O
R
2
.6
8
(9
5
%
C
I
0
.6
4
–
1
.5
3
)
p
0
.0
1
5
w
e
re
si
gn
ifi
ca
n
tl
y
in
d
e
p
e
n
d
e
n
t
ri
sk
fa
ct
o
rs
fo
r
se
ve
re
E
D
co
m
p
ar
e
d
w
it
h
n
o
rm
al
,
m
ild
o
r
m
o
d
e
ra
te
E
D
(2
)
in
o
ld
gr
o
u
p
:
o
n
ly
ag
e
O
R
1
.0
8
(9
5
%
C
I
1
.0
5
–
1
.1
1
)
p
0
.0
0
0
w
as
si
gn
ifi
ca
n
t
in
d
e
p
e
n
d
e
n
t
ri
sk
fa
ct
o
r
fo
r
se
ve
re
E
D
co
m
p
ar
e
d
w
it
h
n
o
rm
al
,
m
ild
o
r
m
o
d
e
ra
te
E
D
.
–
H
B
A
1
c
–
A
ge
–
D
M
d
u
ra
ti
o
n
–
H
T
N
–
D
L
D
–
C
ig
ar
e
tt
e
Sm
o
k
in
g
(c
o
n
ti
n
u
e
d
)
6 Journal of the Royal Society of Medicine Open 0(0)
 at Imperial College London Library on March 10, 2016shr.sagepub.comDownloaded from 
Discussion
Penile erection is deﬁned as the result of smooth
muscle relaxation in the cavernous body and asso-
ciated blood vessels.30 Nitric oxide plays a major
role in this process as it is one of the most important
endogenous smooth muscle relaxants. For chronic
hyperglycaemia and insulin resistance in diabetic
patients, endothelial dysfunction is manifested as a
decreased level of nitric oxide, leading to insuﬃcient
smooth muscle relaxation.
The correlation between glycaemic control and ED
In our systematic review, we identiﬁed ﬁve cross-
sectional studies that examined the association
between the glycaemic control (measured by
HBA1c) and ED (measured by IIEF-5) among type
2 diabetic men. Sixty per cent of included stu-
dies11,17,20 suggested that poor glycaemic control is
positively associated with ED in type 2 diabetics as
the mean HBA1c was found to be higher among
those with ED than those without ED. In the litera-
ture, other studies had also shown positive correl-
ation between poor glycaemic control and ED
among diabetic patients.18
Lu et al.23 showed a signiﬁcant positive associ-
ation between ED and glycaemic control in a
younger age group (60 years), but not in an older
age group (>60 years). Also in the same study, odds
ratio of ED for diﬀerent risk factors, after adjust-
ment for duration of DM and age, showed that the
HBA1c level was signiﬁcantly associated with ED
risk (p 0.034). However, Thomas et al.’s22 study
has shown that patients diagnosed with ED are
mostly older and the commonness of the ED condi-
tion increased with age. Cho et al.8 showed a weak
relationship between HBA1c level and diabetes-
related ED when using a multiple logistic regression
analysis to identify risk factors for all types of ED.
However, in the same study, classifying the patients
based on the level of ED showed the connection
between the severity of ED to HBA1c was signiﬁcant
(p< 0.001).
Several studies had demonstrated an insigniﬁcant
correlation between glycaemic control and ED in dia-
betic men.24–26 In terms of severe (complete) ED, Cho
et al.8 showed a signiﬁcant positive correlation
between complete ED with patients who were on
insulin and patients with either macrovascular disease
or neuropathy. However, complete ED was not sig-
niﬁcantly associated to either smoking status or
hypertension. On the other hand, patients who were
on diet only had rates of complete ED 0.59 times of
those on other treatments, also patients who exer-
cised regularly and those who consumed alcoholT
a
b
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had a lower rate of complete ED than sedentary
patients and those of alcohol abstainers, respectively.
Lu et al.23 showed a signiﬁcant positive association
between severe ED with HBA1c, DM duration and
hypertension among a young age group (60 years),
while only age was a signiﬁcant independent risk
factor for severe ED among an older age group
(>60 years).
In summary, we may conclude that the risk of ED
is higher in type 2 diabetic men with poor glycaemic
control than those with good control, since three stu-
dies showed that there were positive associations
between the two and the other two studies showed
some correlations.
Risk factors for ED
Four of the included studies8,11,20,23 highlighted that
the prevalence of ED was mainly attributable to
patients’ age and the duration of diabetes. This posi-
tive association was conﬁrmed by additional study.31
Only one study17 showed that both subjects’ age and
DM duration were not associated with ED
prevalence.
Two studies8,17 examined the peripheral neur-
opathy and the correlation with ED; both studies
showed signiﬁcant positive association. This was con-
sistent with previous reports.32,33
Two studies11,20 examined the correlation between
body mass index and ED; both studies conﬁrmed a
signiﬁcant association with ED. A similar ﬁnding was
reported by Esposito et al.34
Giugliano et al.20 is the only study that examined
metabolic syndrome, waist hip ratio and depression
and their correlation with ED; all of these factors
were positively associated with ED prevalence.
Hypertension was examined in three studies;8,20,23
only one study20 showed a positive association, which
was supported by previous evidence,35 while the other
two studies did not show any association with ED.
Cigarette smoking was examined in four stu-
dies;8,11,20,23 only one of these studies showed a sig-
niﬁcant correlation between smoking and prevalence
of ED.11 A systematic review of observational studies
came to a conclusion that ED risk is higher in current
and former users of smoking than in those who never
smoke, and smoking cessation may lead to lower risk
of ED than current smoking.36
Dyslipidaemia was examined in Giugliano et al.20
and Lu et al.;23 one study20 showed a positive asso-
ciation and the other study23 did not show that.
In Cho et al.,8 stratifying of the patients according
to ED status (normal, mild, moderate and complete)
showed a signiﬁcant trend connecting the severity of
ED to the duration of alcohol consumption
(p< 0.001), but similarly using multivariate regression
analysis independent predictors for all types of ED:
alcohol consumption (p< 0.05) and exercise
(p< 0.01) were negative independent risk factors of
ED. Additional study by Giugliano et al. showed
that physical activity protected against ED. An assess-
ment of the association between ED and physical
activity was performed in population-based studies
with meta-analysis, and higher physical activity was
seen to lower the risk of ED.37 In Look AHEAD
(action for health in diabetes),31 cardiorespiratory ﬁt-
ness was found to protect ED among the 373 men with
diabetes aged 45–75 years. Further study by De
Berardis et al.4 measured quality of life in diabetic
men with ED and showed that exercise can help pre-
vent ED.
A systematic review of the association between ED
and cardiovascular disease38 has shown that ED
could be a possible sign of systematic endothelial dys-
function. ED usually occurs before cardiovascular
disease and could therefore be an early sign of symp-
tomatic cardiovascular disease.
Limitation of studies
Included studies had some limitations; for example,
there were considerable diﬀerences in study settings,
sample size and in adjustment of confounding fac-
tors. Romeo et al.’s17 study had the lowest sample
size (78 participants). The description of the sam-
pling strategy was not mentioned in El-Sakka and
Tayeb’s study.11 In both studies, there were no
descriptions of the response rate. However, there
were similarities of included studies in terms of
study design since all included studies are cross-sec-
tional studies and they all used IIEF-5 for the deter-
mination of ED and HBA1c to evaluate the
glycaemic control level.
Conclusion
We may conclude that the risk of ED is higher in
type 2 diabetic men with poor glycaemic control
than those with good control. Also, an increase in
patients’ age, DM duration, BMI and peripheral
neuropathy existence can increase the risk of ED
among diabetic men.
This will raise the importance of early screening of
ED among diabetic men and the importance of
HBA1c control as there is supporting evidence for
the reduction of DM complications. We therefore
recommend the incorporation of early ED screening
for all diabetic men alongside the screening of neur-
opathy, retinopathy and nephropathy which are
already endorsed by all existing guidelines.
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